Physician

James Richard Rabago, MD

According to 2025 Medicare claims, James Rabago, MD (NPI: 1467563445) practices family practice in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is MERCED FACULTY ASSOCIATES MEDICAL GROUP, INCORPORATED (NPI: 1003231341) and primary practice location at 95340-0964. Rabago is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), participating under the MSSP model.

Rabago's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,073 traditional Medicare patients, billed 8,788 HCPCS/CPT codes, and received $257,530 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,485 prescription claims across 187 beneficiaries totaling $153,151 in drug costs, led by Rybelsus (Semaglutide). DME data shows 58 claims. Open Payments data shows 3 records totaling $69. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $57,035 to $257,530. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $33,297 to $153,151. In contrast, DME billing represents a smaller volume and rose steadily, from $996 to $11,353.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$129K$258K2015 Medicare payment: $57,035 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $72,280 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $102,894 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $179,459 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $240,057 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $169,571 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $175,881 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $183,902 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $209,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $257,530 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153033,465$57,035
20162713,519$72,280
20171,1704,627$102,894
20181,5706,315$179,459
20191,5577,506$240,057
20201,2168,966$169,571
20211,1206,626$175,881
20221,0616,424$183,902
20231,1057,019$209,115
20241,0738,788$257,530

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$86K$172K2015 Drug cost: $33,297 (USD; Tot_Drug_Cst)2016 Drug cost: $41,224 (USD; Tot_Drug_Cst)2017 Drug cost: $56,500 (USD; Tot_Drug_Cst)2018 Drug cost: $69,974 (USD; Tot_Drug_Cst)2019 Drug cost: $96,546 (USD; Tot_Drug_Cst)2020 Drug cost: $110,393 (USD; Tot_Drug_Cst)2021 Drug cost: $138,693 (USD; Tot_Drug_Cst)2022 Drug cost: $143,620 (USD; Tot_Drug_Cst)2023 Drug cost: $171,866 (USD; Tot_Drug_Cst)2024 Drug cost: $153,151 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201587923$33,297
20161081,105$41,224
20171041,186$56,500
20181011,174$69,974
20191081,359$96,546
20201391,764$110,393
20211682,070$138,693
20221862,319$143,620
20231822,288$171,866
20241872,485$153,151

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.5K$11K2015 Medicare payment: $301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $910 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,236 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,758 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,652 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $585 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,957 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $7,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $7,187 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $11,091 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$301
20161126$910
20171170$1,236
2018N/R70$1,758
20191374$2,652
20201351$585
20212465$1,957
20221286$7,248
2023N/R58$7,187
20241158$11,091

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more264551$82
G0444Annual depression screening, 5 to 15 minutes197197$21
G0442Annual alcohol misuse screening, 5 to 15 minutes212212$21
71046X-ray of chest, 2 views186206$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's223511$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RybelsusSemaglutide14720$19,345
OzempicSemaglutide14518$13,869
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog211,252$8,713
Atorvastatin CalciumAtorvastatin Calcium27822,495$2,994
Lantus SolostarInsulin Glargine,hum.Rec.Anlog271,073$2,778

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceNN/R19$10,830
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsN1128$248
A4259Lancets, per box of 100NN/R11$12

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$69GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Richard Rabago, MD?

Tedicare shows public-source Medicare data for James Richard Rabago, MD (NPI 1467563445), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Richard Rabago, MD have ACO affiliation data?

James Richard Rabago, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542).

What billing organization is linked to James Richard Rabago, MD?

James Richard Rabago, MD is linked to MERCED FACULTY ASSOCIATES MEDICAL GROUP, INCORPORATED (billing NPI 1003231341) in the available physician profile data.

Does James Richard Rabago, MD have Open Payments data?

James Richard Rabago, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.